药物重新定位在状态中的性.
1Department of Clinical and Experimental Epilepsy, University College London Queen Square Institute of Neurology, London WC1N 3BG, UK.
Epilepsy & behavior : E&B
|October 28, 2024
概括
药物重新定位为开发治疗状态 (SE) 的新疗法提供了具有成本效益的解决方案. 新的计算和生物方法可以识别有希望的重用药物,克服传统的发展挑战.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 计算生物学和人工智能的人工智能
背景情况:
- 由于药物开发成本和风险高,状态 (SE) 治疗在过去二十年中取得的进展极小.
- 对于药物开发来说,SE带来了独特的挑战,包括患者的变化以及急性而不是慢性治疗策略的需求.
- 行业对SE新药开发的兴趣有限,需要采用替代方法.
研究的目的:
- 探索药物重用作为一个可行的策略,以解决状态治疗中未满足的需求.
- 展示综合生物和计算方法的应用,用于识别SE的重用药物.
- 通过这些新的方法来突出潜在的候选药物.
主要方法:
- 生物学方法侧重于抗药性机制和SE的长期后果.
- 计算方法,包括人工智能 (AI) 平台和基因表达的in silico分析,以预测分子目标.
- 整合人工智能和in silico发现,以生成和验证潜在的重新用途药物的清单.
主要成果:
- 通过结合AI和in silico方法确定了几种候选药物,包括甲福明,西罗和瑞卢,用于SE治疗.
- 生物学策略探索了耐药性和长期SE影响的机制,建议使用胺和奥马维洛克索隆等药物.
- 药物重定向在缩短开发时间,降低成本和可能更高的成功率方面表现出优势.
结论:
- 药物再利用是一个有希望和可行的解决方案,以加快发展新的治疗状态的治疗方法.
- 尽管存在诸如知识产权和监管障碍等挑战,但重新利用可以克服传统药物开发的缓慢进展和高成本.
- 生物见解与先进的计算方法的整合为未来的SE药物发现提供了一个强大的框架.
更多相关视频
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
17.7K
06:28Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
Published on: September 27, 2024
2.2K
相关概念视频
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1
01:20Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147
01:24Arteries of the Lower Limbs
178
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
336
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
336
01:14Antiepileptic Drugs: Glutamate Antagonists
285
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
285
01:17Antiepileptic Drugs: Calcium Channel Blockers
330
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
330